Diovan Data Was Fabricated, Say Japanese Health Minister And University Officials

Following a long series of accusations, retractions, and the resignation of a prominent professor, it now is clear that data from a large Japanese study of valsartan (Diovan, Novartis) was fabricated. On Thursday officials at Kyoto Prefectural University of Medicine said that “had patient records been used in their entirety,” the Kyoto Heart Study “would have had a different conclusion,” reported AFB. In 2009 the Kyoto Heart Study investigators, including the chief investigator, Hiroaki Matsubara, reported that treatment with valsartan resulted in significant cardiovascular benefits independent of the drug’s blood-pressure lowering effect. Now officials at the university say the drug had no More…
Source: CardioBrief - Category: Cardiology Authors: Tags: People, Places & Events Policy & Ethics Hiroaki Matsubara Japan Kyoto Kyoto Prefectural University of Medicine Novartis scientific misconduct valsartan Source Type: blogs